First research of use Vero-Fludarabine in chronic lymphocytic leukemia and non-hodgkins lymphoma by S. S. Bessmeltsev, K. M. Abdulkadyrov

Get full text

Fludarabin v terapii razlichnykhvariantov nekhodzhkinskikh limfom by S S Bessmel'tsev, K M Abdulkadyrov

Get full text

Vozmozhnosti primeneniya proizvodnykh nitrozometilmocheviny i vepezida v khimioterapii mnozhestvennoy mielomy i zlokachestvennykh limfom by S S Bessmel'tsev, K M Abdulkadyrov

Get full text

Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review) by N. A. Romanenko, K. M. Abdulkadyrov

Get full text

Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review) by N. A. Romanenko, K. M. Abdulkadyrov

Get full text

All we know about polycythemia vera: literature review and own experience by K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Get full text

Dasatinib: ten years of clinical practice worldwide by K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Get full text

Primary myelofibrosis: own experience and news from diagnostic and treatment by K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Get full text

Primary myelofibrosis: own experience and news from diagnostic and treatment by K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Get full text

Korrektsiya anemii u bol'nykh mnozhestvennoy mielomoy s pomoshch'yu eritropoez-stimuliruyushchikh preparatov by N A Romanenko, N A Potikhonova, K M Abdulkadyrov

Get full text

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents by N. A. Romanenko, N. A. Potikhonova, K. M. Abdulkadyrov

Get full text

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents by N. A. Romanenko, N. A. Potikhonova, K. M. Abdulkadyrov

Get full text

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission by V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Get full text

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission by V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Get full text

Influence of TNF-alpha on the efficacy of anemia correction in patients with lymphoproliferative disorders by N. A. Romanenko, S. S. Bessmeltsev, O. E. Rozanova, N. S. Karpova, K. M. Abdulkadyrov

Get full text

Prognostic value of a number of blood laboratory parameters in the use of erythropoiesis-stimulating agents in anemic patients with lymphoproliferative diseases by N A Romanenko, S S Bessmel'tsev, M V Berkos, O E Rozanova, K M Abdulkadyrov

Get full text

Contemporary conceptions of etiology, pathogenesis, management and treatment of primary diffuse large b-cell central nervous system lymphoma by S. V. Voloshin, Yu. A. Krivolapov, A. V. Shmidt, V. A. Shuvaev, M. S. Fominykh, K. M. Abdulkadyrov

Get full text

Contemporary conceptions of etiology, pathogenesis, management and treatment of primary diffuse large b-cell central nervous system lymphoma by S. V. Voloshin, Yu. A. Krivolapov, A. V. Shmidt, V. A. Shuvaev, M. S. Fominykh, K. M. Abdulkadyrov

Get full text

Time course of changes in iron metabolic and oxidative-antioxidative system parameters in patients with acute myeloid leukemia by S V Gritsaev, D I Shikhbabaeva, L P Rybakova, A N Sergeev, S I Kapustin, K M Abdulkadyrov

Get full text

Combination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis by M. S. Fominykh, V. A. Shuvaev, I. S. Martynkevich, L. B. Polushkina, V. Yu. Udal’eva, K. M. Abdulkadyrov

Get full text